NCCN Guidelines Insights: Melanoma, Version 3.2016.
Publication
, Journal Article
Coit, DG; Thompson, JA; Algazi, A; Andtbacka, R; Bichakjian, CK; Carson, WE; Daniels, GA; DiMaio, D; Fields, RC; Fleming, MD; Gastman, B ...
Published in: J Natl Compr Canc Netw
August 2016
The NCCN Guidelines for Melanoma have been significantly revised over the past few years in response to emerging data on a number of novel agents and treatment regimens. These NCCN Guidelines Insights summarize the data and rationale supporting extensive changes to the recommendations for systemic therapy in patients with metastatic or unresectable melanoma.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
August 2016
Volume
14
Issue
8
Start / End Page
945 / 958
Location
United States
Related Subject Headings
- Treatment Outcome
- Retreatment
- Oncology & Carcinogenesis
- Neoplasm Staging
- Molecular Targeted Therapy
- Melanoma
- Immunotherapy
- Humans
- Combined Modality Therapy
- Antineoplastic Combined Chemotherapy Protocols
Citation
APA
Chicago
ICMJE
MLA
NLM
Coit, D. G., Thompson, J. A., Algazi, A., Andtbacka, R., Bichakjian, C. K., Carson, W. E., … Engh, A. (2016). NCCN Guidelines Insights: Melanoma, Version 3.2016. J Natl Compr Canc Netw, 14(8), 945–958. https://doi.org/10.6004/jnccn.2016.0101
Coit, Daniel G., John A. Thompson, Alain Algazi, Robert Andtbacka, Christopher K. Bichakjian, William E. Carson, Gregory A. Daniels, et al. “NCCN Guidelines Insights: Melanoma, Version 3.2016.” J Natl Compr Canc Netw 14, no. 8 (August 2016): 945–58. https://doi.org/10.6004/jnccn.2016.0101.
Coit DG, Thompson JA, Algazi A, Andtbacka R, Bichakjian CK, Carson WE, et al. NCCN Guidelines Insights: Melanoma, Version 3.2016. J Natl Compr Canc Netw. 2016 Aug;14(8):945–58.
Coit, Daniel G., et al. “NCCN Guidelines Insights: Melanoma, Version 3.2016.” J Natl Compr Canc Netw, vol. 14, no. 8, Aug. 2016, pp. 945–58. Pubmed, doi:10.6004/jnccn.2016.0101.
Coit DG, Thompson JA, Algazi A, Andtbacka R, Bichakjian CK, Carson WE, Daniels GA, DiMaio D, Fields RC, Fleming MD, Gastman B, Gonzalez R, Guild V, Johnson D, Joseph RW, Lange JR, Martini MC, Materin MA, Olszanski AJ, Ott P, Gupta AP, Ross MI, Salama AK, Skitzki J, Swetter SM, Tanabe KK, Torres-Roca JF, Trisal V, Urist MM, McMillian N, Engh A. NCCN Guidelines Insights: Melanoma, Version 3.2016. J Natl Compr Canc Netw. 2016 Aug;14(8):945–958.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
August 2016
Volume
14
Issue
8
Start / End Page
945 / 958
Location
United States
Related Subject Headings
- Treatment Outcome
- Retreatment
- Oncology & Carcinogenesis
- Neoplasm Staging
- Molecular Targeted Therapy
- Melanoma
- Immunotherapy
- Humans
- Combined Modality Therapy
- Antineoplastic Combined Chemotherapy Protocols